Thioredoxin-interacting protein mediates TRX1 translocation to the plasma membrane in response to tumor necrosis factor-α A key mechanism for vascular endothelial growth factor receptor-2 transactivation by reactive oxygen species

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 31, Issue 8, 2011, Pages 1890-1897

  World, Cameron ^a,b   Spindel, Oded N ^a,b   Berk, Bradford C ^a,b  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

^b UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

Apoptosis; Redox; Thioredoxin; Thioredoxin interacting protein; Vascular endothelial growth factor receptor 2

Indexed keywords

HYDROGEN PEROXIDE; REACTIVE OXYGEN METABOLITE; THIOREDOXIN 1; THIOREDOXIN INTERACTING PROTEIN; TUMOR NECROSIS FACTOR ALPHA; VASCULAR ENDOTHELIAL CADHERIN; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 2; CARRIER PROTEIN; RECOMBINANT PROTEIN; SMALL INTERFERING RNA; THIOREDOXIN; TXN PROTEIN, HUMAN; TXNIP PROTEIN, HUMAN; TYROSINE;

APOPTOSIS; ARTICLE; CELL FRACTIONATION; CELL MEMBRANE; CELL MIGRATION; CELL SURVIVAL; CONTROLLED STUDY; ENDOTHELIUM CELL; EPIFLUORESCENCE MICROSCOPY; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE MICROSCOPY; IMMUNOFLUORESCENCE TEST; INFLAMMATION; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN PHOSPHORYLATION; TRANSACTIVATION; WESTERN BLOTTING; AMINO ACID SUBSTITUTION; CELL CULTURE; CELL MOTION; CHEMISTRY; DRUG ANTAGONISM; DRUG EFFECT; GENE SILENCING; GENETICS; METABOLISM; NUCLEOTIDE SEQUENCE; PHOSPHORYLATION; PHYSIOLOGY; PROTEIN DOMAIN; PROTEIN TRANSPORT; SIGNAL TRANSDUCTION; SITE DIRECTED MUTAGENESIS; TRANSCRIPTION INITIATION;

AMINO ACID SUBSTITUTION; BASE SEQUENCE; CARRIER PROTEINS; CELL MOVEMENT; CELL SURVIVAL; CELLS, CULTURED; ENDOTHELIAL CELLS; GENE KNOCKDOWN TECHNIQUES; HUMANS; MUTAGENESIS, SITE-DIRECTED; OXIDATION-REDUCTION; PHOSPHORYLATION; PROTEIN INTERACTION DOMAINS AND MOTIFS; PROTEIN TRANSPORT; REACTIVE OXYGEN SPECIES; RECOMBINANT PROTEINS; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; THIOREDOXINS; TRANSCRIPTIONAL ACTIVATION; TUMOR NECROSIS FACTOR-ALPHA; TYROSINE; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2;

EID: 80052882481     PISSN: 10795642     EISSN: 15244636     Source Type: Journal    
DOI: 10.1161/ATVBAHA.111.226340     Document Type: Article

References (44)

1. Powis G, Mustacich D, Coon A. The role of the redox protein thioredoxin in cell growth and cancer. Free Radic Biol Med. 2000;29:312-322.
2. World CJ, Yamawaki H, Berk BC. Thioredoxin in the cardiovascular system. J Mol Med. 2006;84:997-1003.
3. 2. J Biol Chem. 2002;277:20336-20342. (Pubitemid 34967328)
4. Lee SR, Kwon KS, Kim SR, Rhee SG. Reversible inactivation of proteintyrosine phosphatase 1B in A431 cells stimulated with epidermal growth factor. J Biol Chem. 1998;273:15366-15372. (Pubitemid 28298140)
5. 2 and reactivation by thioredoxin. J Biol Chem. 2008;283:12373-12386.
6. Nishiyama A, Matsui M, Iwata S, Hirota K, Masutani H, Nakamura H, Takagi Y, Sono H, Gon Y, Yodoi J. Identification of thioredoxin-binding protein-2/vitamin D (3) up-regulated protein 1 as a negative regulator of thioredoxin function and expression. J Biol Chem. 1999;274:21645-21650.
7. 3 up-regulated protein 1 mediates oxidative stress via suppressing the thioredoxin function. J Immunol. 2000;164:6287-6295. (Pubitemid 30408809)
8. Patwari P, Higgins LJ, Chutkow WA, Yoshioka J, Lee RT. The interaction of thioredoxin with Txnip: evidence for formation of a mixed disulfide by disulfide exchange. J Biol Chem. 2006.
9. Ago T. A redox-dependent pathway for regulating class II HDACs and cardiac hypertrophy. Cell. 2008;133:978-993. (Pubitemid 351787743)
10. Malik G, Gorbounov N, Das S, Gurusamy N, Otani H, Maulik N, Goswami S, Das DK. Ischemic preconditioning triggers nuclear translocation of thioredoxin and its interaction with Ref-1 potentiating a survival signal through the PI-3-kinase-Akt pathway. Antioxid Redox Signal. 2006;8:2101-2109. (Pubitemid 46489634)
11. Liu H, Nishitoh H, Ichijo H, Kyriakis JM. Activation of apoptosis signalregulating kinase 1 (ASK1) by tumor necrosis factor receptor-associated factor 2 requires prior dissociation of the ASK1 inhibitor thioredoxin. Mol Cell Biol. 2000;20:2198-2208. (Pubitemid 30123835)
12. Liu Y, Min W. Thioredoxin promotes ASK1 ubiquitination and degradation to inhibit ASK1-mediated apoptosis in a redox activityindependent manner. Cir Res. 2002;90:1259-1266. (Pubitemid 34787407)
13. Yamawaki H, Pan S, Lee RT, Berk BC. Fluid shear stress inhibits vascular inflammation by decreasing thioredoxin-interacting protein in endothelial cells. J Clin Invest. 2005;115:733-738. (Pubitemid 40322249)
14. Yamawaki H, Lehoux S, Berk BC. Chronic physiological shear stress inhibits tumor necrosis factor-induced proinflammatory responses in rabbit aorta perfused ex vivo. Circulation. 2003;108:1619-1625. (Pubitemid 37187790)
15. Erclik MS, Mitchell J. The role of protein kinase C-δ in PTH stimulation of IGF-binding protein-5 mRNA in UMR-106-01 cells. Am J Physiol Endocrinol Metab. 2002;282:E534-E541. (Pubitemid 34654767)
16. Cavet ME, Smolock EM, Ozturk OH, World C, Pang J, Konishi A, Berk BC. Gas6-axl receptor signaling is regulated by glucose in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol. 2008;28:886-891. (Pubitemid 351544103)
17. Pan S, World CJ, Kovacs CJ, Berk BC. Glucose 6-phosphate dehydrogenase is regulated through c-Src-mediated tyrosine phosphorylation in endothelial cells. Arterioscler Thromb Vasc Biol. 2009;29:895-901.
18. Pi X, Garin G, Xie L, Zheng Q, Wei H, Abe J, Yan C, Berk BC. BMK1/ERK5 is a novel regulator of angiogenesis by destabilizing hypoxia inducible factor 1a. Circ Res. 2005;96:1145-1151. (Pubitemid 40827689)
19. Frey RS, Gao X, Javaid K, Siddiqui SS, Rahman A, Malik AB. Phosphatidylinositol 3-kinase-γ signaling through protein kinase Cζ induces NADPH oxidase-mediated oxidant generation and NF-κB activation in endothelial cells. J Biol Chem. 2006;281:16128-16138. (Pubitemid 43848508)
20. Li JM, Fan LM, Christie MR, Shah AM. Acute tumor necrosis factor α signaling via NADPH oxidase in microvascular endothelial cells: role of p47phox phosphorylation and binding to TRAF4. Mol Cell Biol. 2005;25:2320-2330. (Pubitemid 40354628)
21. Nishinaka Y, Masutani H, Oka S, Matsuo Y, Yamaguchi Y, Nishio K, Ishii Y, Yodoi J. Importin α1 (Rch1) mediates nuclear translocation of thioredoxin-binding protein-2/vitamin D (3)-up-regulated protein 1. J Biol Chem. 2004;279:37559-37565. (Pubitemid 39195469)
22. Thurmond DC, Ceresa BP, Okada S, Elmendorf JS, Coker K, Pessin JE. Regulation of insulin-stimulated GLUT4 translocation by Munc18c in 3T3L1 adipocytes. J Biol Chem. 1998;273:33876-33883.
23. Suzuki J, Jin ZG, Meoli DF, Matoba T, Berk BC. Cyclophilin A is secreted by a vesicular pathway in vascular smooth muscle cells. Circ Res. 2006;98:811-817.
24. Yoshizumi M, Abe J, Haendeler J, Huang Q, Berk BC. Src and cas mediate JNK activation but not ERK1/2 and p38 kinases by reactive oxygen species. J Biol Chem. 2000;275:11706-11712. (Pubitemid 30237733)
25. Chen K, Thomas SR, Albano A, Murphy MP, Keaney JF Jr. Mitochondrial function is required for hydrogen peroxide-induced growth factor receptor transactivation and downstream signaling. J Biol Chem. 2004;279:35079-35086. (Pubitemid 39318144)
26. Ushio-Fukai M, Tang Y, Fukai T, Dikalov SI, Ma Y, Fujimoto M, Quinn MT, Pagano PJ, Johnson C, Alexander RW. Novel role of gp91 (phox) - containing NAD (P) H oxidase in vascular endothelial growth factorinduced signaling and angiogenesis. Circ Res. 2002;91:1160-1167. (Pubitemid 36076365)
27. Datla SR, Peshavariya H, Dusting GJ, Mahadev K, Goldstein BJ, Jiang F. Important role of Nox4 type NADPH oxidase in angiogenic responses in human microvascular endothelial cells in vitro. Arterioscler Thromb Vasc Biol. 2007;27:2319-2324. (Pubitemid 350203945)
28. Jeon JH, Lee KN, Hwang CY, Kwon KS, You KH, Choi I. Tumor suppressor VDUP1 increases p27 (kip1) stability by inhibiting JAB1. Cancer Res. 2005;65:4485-4489. (Pubitemid 40740780)
29. Saxena G, Chen J, Shalev A. Intracellular shuttling and mitochondrial function of thioredoxin-interacting protein. J Biol Chem. 2009.
30. Alvarez CE. On the origins of arrestin and rhodopsin. BMC Evol Biol. 2008;8:222.
31. Lin CH, MacGurn JA, Chu T, Stefan CJ, Emr SD. Arrestin-related ubiquitin-ligase adaptors regulate endocytosis and protein turnover at the cell surface. Cell. 2008;135:714-725.
32. Herranz S, Rodriguez JM, Bussink HJ, Sanchez-Ferrero JC, Arst HN Jr, Penalva MA, Vincent O. Arrestin-related proteins mediate pH signaling in fungi. Proc Natl Acad Sci USA. 2005;102:12141-12146. (Pubitemid 41291142)
33. Nikko E, Sullivan JA, Pelham HR. Arrestin-like proteins mediate ubiquitination and endocytosis of the yeast metal transporter Smf1. EMBO Rep. 2008;9:1216-1221.
34. Miller WE, Maudsley S, Ahn S, Khan KD, Luttrell LM, Lefkowitz RJ. β-Arrestin1 interacts with the catalytic domain of the tyrosine kinase c-SRC: role of β-arrestin1-dependent targeting of c-SRC in receptor endocytosis. J Biol Chem. 2000;275:11312-11319. (Pubitemid 30212780)
35. Luttrell LM, Ferguson SS, Daaka Y, Miller WE, Maudsley S, Della Rocca GJ, Lin F, Kawakatsu H, Owada K, Luttrell DK, Caron MG, Lefkowitz RJ. β-Arrestin-dependent formation of β2 adrenergic receptor-Src protein kinase complexes. Science. 1999;283:655-661.
36. D'Angelo G, Martini JF, Iiri T, Fantl WJ, Martial J, Weiner RI. 16K human prolactin inhibits vascular endothelial growth factor-induced activation of Ras in capillary endothelial cells. Mol Endocrinol. 1999;13:692-704. (Pubitemid 30645323)
37. Agazie YM, Hayman MJ. Molecular mechanism for a role of SHP2 in epidermal growth factor receptor signaling. Mol Cell Biol. 2003;23:7875-7886. (Pubitemid 37271483)
38. 2 for platelet-derived growth factor signal transduction. Science. 1995;270:296-299.
39. Choi MH, Lee IK, Kim GW, Kim BU, Han YH, Yu DY, Park HS, Kim KY, Lee JS, Choi C, Bae YS, Lee BI, Rhee SG, Kang SW. Regulation of PDGF signalling and vascular remodelling by peroxiredoxin II. Nature. 2005;435:347-353. (Pubitemid 40745544)
40. Woo HA, Yim SH, Shin DH, Kang D, Yu DY, Rhee SG. Inactivation of peroxiredoxin I by phosphorylation allows localized H (2) O (2) accumulation for cell signaling. Cell; 140:517-528.
41. Obikane H, Abiko Y, Ueno H, Kusumi Y, Esumi M, Mitsumata M. Effect of endothelial cell proliferation on atherogenesis: a role of p21 (Sdi/Cip/Waf1) in monocyte adhesion to endothelial cells. Atherosclerosis. 2010;212:116-122.
42. Han SH, Jeon JH, Ju HR, Jung U, Kim KY, Yoo HS, Lee YH, Song KS, Hwang HM, Na YS, Yang Y, Lee KN, Choi I. VDUP1 upregulated by TGF-β1 and 1, 25-dihydorxyvitamin D3 inhibits tumor cell growth by blocking cell-cycle progression. Oncogene. 2003;22:4035-4046. (Pubitemid 36819644)
43. Minn AH, Hafele C, Shalev A. Thioredoxin-interacting protein is stimulated by glucose through a carbohydrate response element and induces β-cell apoptosis. Endocrinology. 2005;146:2397-2405. (Pubitemid 40577527)
44. Chen J, Hui ST, Couto FM, Mungrue IN, Davis DB, Attie AD, Lusis AJ, Davis RA, Shalev A. Thioredoxin-interacting protein deficiency induces Akt/Bcl-xL signaling and pancreatic β-cell mass and protects against diabetes. FASEB J. 2008.